Standout Papers

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics 2017 2026 2020 2023 396
  1. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics (2017)
    Peter Bannas, Julia Hambach et al. Frontiers in Immunology

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Mechanistic insights into Wnt–β-catenin pathway activation and signal transduction
2025 Standout
3 intermediate papers

Works of Julia Hambach being referenced

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
2017 Standout

Author Peers

Author Last Decade Papers Cites
Julia Hambach 329 267 189 210 13 577
Simone C. Oostindie 342 201 187 260 14 557
Hennie R. Hoogenboom 401 440 125 148 10 654
Lisa D. Taylor 364 393 95 222 15 593
Dean O. Campbell 91 332 168 77 19 602
Andreas Wagner 120 428 132 211 12 621
Letitia A. Wims 392 368 71 189 21 611
Dale E. Yelton 398 304 66 249 10 619
L J Hefta 331 398 204 121 15 658
Erica Browning 83 266 91 443 10 700
Cécile Artaud 84 348 54 159 19 571

All Works

Loading papers...

Rankless by CCL
2026